Imaging prediction of KRAS mutation in patients with rectal cancer through deep metric learning using pretreatment [18F]Fluorodeoxyglucose positron emission tomography/computed tomography

Br J Radiol. 2023 Nov;96(1151):20230243. doi: 10.1259/bjr.20230243. Epub 2023 Oct 11.

Abstract

Objectives: To predict KRAS mutation in rectal cancer (RC) through computer vision of [18F]fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) by using metric learning (ML).

Methods: This study included 160 patients with RC who had undergone preoperative PET/CT. KRAS mutation was identified through polymerase chain reaction analysis. This model combined ML with the deep-learning framework to analyze PET data with or without CT images. The Batch Balance Wrapper framework and K-fold cross-validation were employed during the learning process. A receiver operating characteristic (ROC) curve analysis was performed to assess the model's predictive performance.

Results: Genetic alterations in KRAS were identified in 82 (51%) tumors. Both PET and CT images were used, and the proposed model had an area under the ROC curve of 0.836 for its ability to predict a mutation status. The sensitivity, specificity, and accuracy were 75.3%, 79.3%, and 77.5%, respectively. When PET images alone were used, the area under the curve was 0.817, whereas the sensitivity, specificity, and accuracy were 73.2%, 79.6%, and 76.2%, respectively.

Conclusions: The ML model presented herein revealed that baseline 18F-FDG PET/CT images could provide supplemental information to determine KRAS mutation in RC. Additional studies are required to maximize the predictive accuracy.

Advances in knowledge: The results of the ML model presented herein indicate that baseline 18F-FDG PET/CT images could provide supplemental information for determining KRAS mutation in RC.The predictive accuracy of the model was 77.5% when both image types were used and 76.2% when PET images alone were used. Additional studies are required to maximize the predictive accuracy.

MeSH terms

  • Fluorodeoxyglucose F18
  • Humans
  • Mutation
  • Positron Emission Tomography Computed Tomography*
  • Positron-Emission Tomography / methods
  • Proto-Oncogene Proteins p21(ras) / genetics
  • Radiopharmaceuticals
  • Rectal Neoplasms* / diagnostic imaging
  • Rectal Neoplasms* / genetics

Substances

  • Fluorodeoxyglucose F18
  • Proto-Oncogene Proteins p21(ras)
  • Radiopharmaceuticals
  • KRAS protein, human